drugset / Trial / NCT00450775

Evaluation of the Efficacy, Tolerability, and Patient Acceptance of Dermatix Q for the Prevention and Management of Scars

NCT00450775 ↗

Phase 4 Completed 12 enrolled Innovative Medical
RandomizedSingle-groupOpen-labelPrevention

Summary

The purpose of this study is to evaluate the efficacy and patient acceptance of Dermatix Q for the prevention and treatment of scarring.

Timeline

Start
2007-03
Primary completion
2008-03
Completion
2008-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Dermatix Q Unknown — —

Indications

No indication recorded.